A1RG34:BVMF
Argenx Se Bdr
R$ १८७.३८
arrow_upward
+१.९९%(+३.६५) 1D
अक्टोबर ६, १४:०५:५४ GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
R$ १८७.३८
High
R$ १८७.३८
Low
R$ १८७.३८
Mkt. cap
५८.२७ अरब
Avg. vol.
५७.००
Volume
१०.००
52-wk high
R$ २१३.१५
52-wk low
R$ १४३.२२
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
Open
R$ १८७.३८
High
R$ १८७.३८
Low
R$ १८७.३८
Mkt. cap
५८.२७ अरब
Avg. vol.
५७.००
Volume
१०.००
52-wk high
R$ २१३.१५
52-wk low
R$ १४३.२२
Shares outstanding
६.२६ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
AD HOC NEWS
·
३ घण्टा पहिले
argenx stock: New VYVGART data span myasthenia gravis and CIDP
AD HOC NEWS
·
२२ घण्टा पहिले
Argenx stock gets fresh VYVGART data before Q3 results
The Motley Fool
·
१ दिन पहिले
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr